Bridge Grants Program: The intent of this grant mechanism is to provide interim support for existing investigator-initiated, cancer-related, research projects that have been highly rated by national panels of peer reviewers in recent federal competitions but were not funded. Allowable federal competitions include but are not limited to those conducted by the National Institutes of Health, the Department of Defense Congressionally Directed Medical Research Programs, etc. The applicant must have received a peer review summary statement indicating high scientific merit. Applications for bridge funding on proposals that were not scored will not be accepted for funding.
The deadline for receipt of applications is October 1, 2014.
Applications should be submitted to both:
- Cancer Preeminence Coordinating Committee, P.O. Box 100014, Gainesville, FL 32610-0014 and
- Dr. Paul Okunieff, PO Box 103633, Gainesville, FL 32610
It is anticipated that up to 10 proposals will be funded each year, with proposal deadlines on a semiannual basis, pending the quality of science and availability of funds. The maximum award for these grants is $50,000 direct cost each. No IDC is allowed. The award is for a period of one year with the expectation that all the funds will be expended during that term.